Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
British Journal of Haematology
|
April 1, 1997
Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma. Nordic Myeloma Study Group
F Wisløff, M Hjorth
Lupus
|
February 7, 2017
Successful treatment of refractory systemic lupus erythematosus using proteasome inhibitor bortezomib followed by belimumab: description of two cases
C Sjöwall, M Hjorth, P Eriksson
Scandinavian Journal of Infectious Diseases
|
January 1, 1980
Empiric treatment of fever in acute leukaemia with tobramycin-cephalothin, and the escape clause provision of corticosteroids
M Hjorth, A Weinfeld, J E Brorson
European Journal of Haematology
|
September 28, 2000
Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group
L M Knudsen, M Hjorth, E Hippe
Environmental Technology
|
April 8, 2014
The effect of residual cationic polymers in swine wastewater on the fouling of reverse osmosis membranes
C O Pedersen, L Masse, M Hjorth
Physical Review Letters
|
May 21, 2010
Ab initio computation of the 17F proton halo state and resonances in A = 17 nuclei
G Hagen, T Papenbrock, M Hjorth-Jensen
Molecular Pharmacology
|
March 1, 1982
Chlorpromazine, methotrimeprazine, and metabolites. Structural changes accompanying the loss of neuroleptic potency by ring sulfoxidation
S G Dahl, M Hjorth, E Hough
Drug and Alcohol Dependence
|
April 1, 1981
Serum tryptophan levels in alcoholics
M Hjorth, M Bille, D F Smith
Aquatic Toxicology (Amsterdam, Netherlands)
|
December 15, 2005
Effects on the function of three trophic levels in marine plankton communities under stress from the antifouling compound zinc pyrithione
M Hjorth, I Dahllöf, V E Forbes
British Journal of Haematology
|
August 1, 1996
Effect of interferon on the health-related quality of life of multiple myeloma patients: results of a Nordic randomized trial comparing melphalan-prednisone to melphalan-prednisone + alpha-interferon. The Nordic Myeloma Study Group
F Wisløff, M Hjorth, S Kaasa, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
British Journal of Haematology
|
April 1, 1997
Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma. Nordic Myeloma Study Group
F Wisløff, M Hjorth
Lupus
|
February 7, 2017
Successful treatment of refractory systemic lupus erythematosus using proteasome inhibitor bortezomib followed by belimumab: description of two cases
C Sjöwall, M Hjorth, P Eriksson
Scandinavian Journal of Infectious Diseases
|
January 1, 1980
Empiric treatment of fever in acute leukaemia with tobramycin-cephalothin, and the escape clause provision of corticosteroids
M Hjorth, A Weinfeld, J E Brorson
European Journal of Haematology
|
September 28, 2000
Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group
L M Knudsen, M Hjorth, E Hippe
Environmental Technology
|
April 8, 2014
The effect of residual cationic polymers in swine wastewater on the fouling of reverse osmosis membranes
C O Pedersen, L Masse, M Hjorth
Physical Review Letters
|
May 21, 2010
Ab initio computation of the 17F proton halo state and resonances in A = 17 nuclei
G Hagen, T Papenbrock, M Hjorth-Jensen
Molecular Pharmacology
|
March 1, 1982
Chlorpromazine, methotrimeprazine, and metabolites. Structural changes accompanying the loss of neuroleptic potency by ring sulfoxidation
S G Dahl, M Hjorth, E Hough
Drug and Alcohol Dependence
|
April 1, 1981
Serum tryptophan levels in alcoholics
M Hjorth, M Bille, D F Smith
Aquatic Toxicology (Amsterdam, Netherlands)
|
December 15, 2005
Effects on the function of three trophic levels in marine plankton communities under stress from the antifouling compound zinc pyrithione
M Hjorth, I Dahllöf, V E Forbes
British Journal of Haematology
|
August 1, 1996
Effect of interferon on the health-related quality of life of multiple myeloma patients: results of a Nordic randomized trial comparing melphalan-prednisone to melphalan-prednisone + alpha-interferon. The Nordic Myeloma Study Group
F Wisløff, M Hjorth, S Kaasa, et al.
Page
of 6